1,254
Views
5
CrossRef citations to date
0
Altmetric
Research Article

What is the difference in ablation zone of multi-bipolar radiofrequency ablation between liver cirrhosis and normal liver background? – a prospective clinical study

ORCID Icon, ORCID Icon, , , , ORCID Icon, , & ORCID Icon show all
Pages 1248-1259 | Received 13 Mar 2020, Accepted 13 Oct 2020, Published online: 08 Nov 2020

References

  • Ahmed M, Solbiati L, Brace CL, et al.; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273:241–260.
  • Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317–370.
  • Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265:958–968.
  • Kim YS, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013;58:89–97.
  • Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28:493–508.
  • Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010;30:3–16.
  • McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19:3–23.
  • Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684–692.
  • Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234:954–960.
  • Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003;38:977–981.
  • Washburn WK, Dodd GD, 3rd, Kohlmeier RE, et al. Radiofrequency tissue ablation: effect of hepatic blood flow occlusion on thermal injuries produced in cirrhotic livers. Ann Surg Oncol. 2003;10:773–777.
  • Bitsch RG, Dux M, Helmberger T, et al. Effects of vascular perfusion on coagulation size in radiofrequency ablation of ex vivo perfused bovine livers. Invest Radiol. 2006;41:422–427.
  • Dodd GD, 3rd, Dodd NA, Lanctot AC, et al. Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model. Radiology. 2013;267:129–136.
  • Pillai K, Akhter J, Chua TC, et al. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine (Baltimore). 2015;94:e580.
  • Liu Z, Ahmed M, Sabir A, et al. Computer modeling of the effect of perfusion on heating patterns in radiofrequency tumor ablation. Int J Hyperthermia. 2007;23:49–58.
  • Huang L, Dodd GD, 3rd, Lanctot AC. Radiofrequency ablation of the liver: effect of variation of portal venous blood flow on lesion size in an in-vitro perfused bovine liver. Acad Radiol. 2012;19:1018–1022.
  • Dodd GD, 3rd, Lanctot AC, Lind KE. Effect of change in portal vein flow rates on hepatic ablations created with a bipolar radiofrequency ablation device. Radiology. 2017;283:399–407.
  • Ahmed M, Liu Z, Humphries S, et al. Computer modeling of the combined effects of perfusion, electrical conductivity, and thermal conductivity on tissue heating patterns in radiofrequency tumor ablation. Int J Hyperthermia. 2008;24:577–588.
  • Iwamoto T, Kawai N, Sato M, et al. Effectiveness of hepatic arterial embolization on radiofrequency ablation volume in a swine model: relationship to portal venous flow and liver parenchymal pressure. J Vasc Interv Radiol. 2008;19:1646–1651.
  • Huber A, Ebner L, Heverhagen JT, et al. State-of-the-art imaging of liver fibrosis and cirrhosis: a comprehensive review of current applications and future perspectives. Eur J Radiol Open. 2015;2:90–100.
  • Papadatos D, Fowler KJ, Kielar AZ, et al. Cirrhosis and LI-RADS. Abdom Radiol (NY). 2018;43:26–40.
  • Shiha G, Ibrahim A, Helmy A, et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11:1–30.
  • Chang S, Lanctot AC, McCarter MD, et al. The prediction of radiofrequency ablation zone volume using vascular indices of 3-dimensional volumetric colour Doppler ultrasound in an in vitro blood-perfused bovine liver model. Br J Radiol. 2017;90:20160661.
  • European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.
  • Liu Z, Ahmed M, Weinstein Y, et al. Characterization of the RF ablation-induced ‘oven effect’: the importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia. 2006;22:327–342.
  • Cassinotto C, Denys A, Gay F, et al. Radiofrequency ablation of liver tumors: no difference in the ablation zone volume between cirrhotic and healthy liver. Cardiovasc Intervent Radiol. 2018;41:905–911.
  • Afif AM, Chang JP-E, Wang YY, et al. A sonographic Doppler study of the hepatic vein, portal vein and hepatic artery in liver cirrhosis: Correlation of hepatic hemodynamics with clinical Child Pugh score in Singapore. Ultrasound. 2017;25:213–221.
  • Sudhamshu KC, Matsutani S, Maruyama H, et al. Doppler study of hepatic vein in cirrhotic patients: correlation with liver dysfunction and hepatic hemodynamics. WJG. 2006;12:5853–5858.
  • Chen CH, Lin ST, Yang CC, et al. The accuracy of sonography in predicting steatosis and fibrosis in chronic hepatitis C. Dig Dis Sci. 2008;53:1699–1706.
  • Hohmann J, Muller C, Oldenburg A, et al. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: a prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers. Ultrasound Med Biol. 2009;35:1427–1435.
  • Zhou JH, Li AH, Cao LH, et al. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound. BJR. 2008;81:113–119.
  • Abbattista T, Ridolfi F, Consalvo GT, et al. Hepatic vein arrival time for diagnosis of liver cirrhosis: a 10-year single-center experience with contrast-enhanced sonography. J Ultrasound Med. 2016;35:2121–2128.
  • Shi Y, Wang XH, Xia GC, et al. Quantitative diagnosis of early-stage liver cirrhosis with contrast-enhanced ultrasound–a clinical study. Adv Clin Exp Med. 2012;21:385–390.
  • Kruskal JB, Thomas P, Kane RA, et al. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology. 2004;231:482–490.
  • Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655–1669.
  • Thabut D, Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol. 2010;53:976–980.
  • Ahmed M, Liu Z, Afzal KS, et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology. 2004;230:761–767.
  • Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166–175.
  • Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29:2698–2705.